Why REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

Learn more about REXULTI for agitation that may happen with dementia due to Alzheimer’s disease. See Important Safety Info and Full Prescribing Info, including Boxed WARNING.

REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

Otsuka Pharmaceutical and Lundbeck present positive results showing reduced agitation in patients with Alzheimer's dementia treated with brexpiprazole at the 2022 Alzheimer's Association International Conference

JAMA Neurology Publishes Complete Results of Positive Phase 3 Study of REXULTI® (brexpiprazole) for Agitation Associated with Dementia Due to Alzheimer's Disease

REXULTI® (brexpiprazole), Agitation associated with dementia due to Alzheimer's disease

Medications for Memory Loss

Psych News Alert: FDA Approves Rexulti for Agitation Associated With Dementia Due to Alzheimer's Disease

FDA approves first drug meant to ease Alzheimer's-linked agitation

FDA rushes approval of dementia drug that quadruples risk of death

REXULTI® (brexpiprazole), Agitation associated with dementia due to Alzheimer's disease

Medicare coverage debates amplify as FDA approves Rexulti for Alzheimer's agitation